Pfizer said the patient, a young boy who was treated earlier last year, had died suddenly. The company is working with trial researchers to investigate further.

Anglo-Swedish drugmaker AstraZeneca is withdrawing its COVID-19 vaccine worldwide, the Telegraph reported on Tuesday. The vaccine can no longer be used in the European Union after the company ...

"It has been a steady start to 2024 – and despite some challenges the biopharmaceutical sector is facing in the financial markets amid stubborn inflation and stalled interest ra ...

In March, we announced that the Phase 3 SYMPHONY trial of AXS-12 in narcolepsy achieved its primary endpoint and ...

VALIANT is a randomized, placebo-controlled, double-blinded, multi-center study designed to evaluate the safety and efficacy of systemic pegcetacoplan in 124 patients aged 12 and up with either C3G or ...

Two articles published in the New England Journal of Medicine reporting results from the Phase 2b FRONTIER 1 study with JNJ-2113 and the Phase 2 REVIVE study with rusfertide NEWARK, CA / ACCESSWIRE / ...